Publications by authors named "Victoria Warbey"

Claim this Profile
D
Diagnostic performance of quantitative measures from [F]FDG PET/CT, [F]FEC PET/CT, and DW-MRI in the detection of lymph node metastases in endometrial and cervical cancer: data from the MAPPING study.
Ben G King, Nishat Bharwani, William Wilson, Gary J R Cook, Aslam Sohaib, Victoria Warbey

Eur J Nucl Med Mol Imaging· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interobserver variability in interim PET assessment in Hodgkin lymphoma-reasons and solutions.
Thomas W Georgi, Lars Kurch, Dirk Hasenclever, Victoria S Warbey, Lucy Pike

PLoS One· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic Accuracy of FEC-PET/CT, FDG-PET/CT, and Diffusion-Weighted MRI in Detection of Nodal Metastases in Surgically Treated Endometrial and Cervical Carcinoma.
Andrea G Rockall, Tara D Barwick, William Wilson, Naveena Singh, Nishat Bharwani, Victoria Warbey

Clin Cancer Res· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDG PET-CT imaging in head and neck paragangliomas: A centre experience.
Sarah Boughdad, Ann O'Connor, Gary J Cook, Lucy Pike, Steve Connor, Victoria Warbey

Clin Endocrinol (Oxf)· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of a UK National Cancer Research Institute Phase II study of brentuximab vedotin using a response-adapted design in the first-line treatment of patients with classical Hodgkin lymphoma unsuitable for chemotherapy due to age, frailty or comorbidity (BREVITY).
Adam Gibb, Sarah J Pirrie, Kim Linton, Victoria Warbey, Kathryn Paterson

Br J Haematol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II, Open-label study to assess safety and management change using Ga-THP PSMA PET/CT in patients with high risk primary prostate cancer or biochemical recurrence after radical treatment: The PRONOUNCED study.
Asim Afaq, Heather Payne, Reena Davda, John Hines, Gary J R Cook, Victoria S Warbey

J Nucl Med· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative assessment of interim PET in Hodgkin lymphoma: An evaluation of the qPET method in adult patients in the RAPID trial.
Thomas W Georgi, Lars Kurch, Dirk Hasenclever, Victoria S Warbey, Lucy Pike

PLoS One· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of F-Fluciclovine Positron Emission Tomography on the Management of Patients With Recurrence of Prostate Cancer: Results From the FALCON Trial.
Andrew F Scarsbrook, David Bottomley, Eugene J Teoh, Kevin M Bradley, Heather Payne, Victoria S Warbey

Int J Radiat Oncol Biol Phys· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The management impact of gallium-tris(hydroxypyridinone) prostate-specific membrane antigen (Ga-THP-PSMA) PET-CT imaging for high-risk and biochemically recurrent prostate cancer.
Meghana Kulkarni, Simon Hughes, Andrew Mallia, Victoria Gibson, Jennifer Young, Victoria S Warbey

Eur J Nucl Med Mol Imaging· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study to assess the safety and efficacy of the dual mTORC1/2 inhibitor vistusertib in relapsed, refractory DLBCL.
Toby A Eyre, Catherine Hildyard, Angela Hamblin, Ayesha S Ali, Aimee Houlton, Victoria Warbey

Hematol Oncol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PSMA PET/CT imaging for primary staging of intermediate and high-risk prostate cancer.
Gary J R Cook, Meghana Kulkarni, Victoria S Warbey

BJU Int· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
UK guidelines on 18F-fluciclovine PET/CT in prostate cancer imaging.
Asim Afaq, Fergus Gleeson, Andrew Scarsbrook, Kevin Bradley, Manil Subesinghe, Victoria S Warbey

Nucl Med Commun· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of post-injection F-FDG PET scanning time on texture analysis of peripheral nerve sheath tumours in neurofibromatosis-1.
Eitan Lovat, Musib Siddique, Vicky Goh, Rosalie E Ferner, Gary J R Cook, Victoria S Warbey

EJNMMI Res· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterisation of malignant peripheral nerve sheath tumours in neurofibromatosis-1 using heterogeneity analysis of F-FDG PET.
Gary J R Cook, Eitan Lovat, Muhammad Siddique, Vicky Goh, Rosalie Ferner, Victoria S Warbey

Eur J Nucl Med Mol Imaging· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advanced vulvar apocrine carcinoma expressing estrogen receptors that responds to tamoxifen therapy.
Robert Goldstein, Catherine M Stefanato, Victoria Warbey, Mark Harries

Future Oncol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interim fluoro-2-deoxy-D-glucose-PET predicts response and progression-free survival in patients with Hodgkin lymphoma and HIV infection.
Jessica Okosun, Victoria Warbey, Kate Shaw, Silvia Montoto, Paul Fields

AIDS· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Routine bone marrow biopsy is not necessary in the staging of patients with classical Hodgkin lymphoma in the 18F-fluoro-2-deoxyglucose positron emission tomography era.
Simon E Richardson, Jagoda Sudak, Victoria Warbey, Alan Ramsay, Christopher J McNamara

Leuk Lymphoma· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinico-pathologic characteristics of patients with hepatic lymphoma diagnosed using image-guided liver biopsy techniques.
Dima El-Sharkawi, Alan Ramsay, Kate Cwynarski, Derralynn Hughes, Archie Prentice, Victoria Warbey

Leuk Lymphoma· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[18F]FDG PET/CT in the diagnosis of malignant peripheral nerve sheath tumours in neurofibromatosis type-1.
Victoria S Warbey, Rosalie E Ferner, Joel T Dunn, Eduardo Calonje, Michael J O'Doherty

Eur J Nucl Med Mol Imaging· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuroendocrine tumors: role of interventional radiology in therapy.
Michael J Steward, Victoria S Warbey, Anmol Malhotra, Martyn E Caplin, John R Buscombe

Radiographics· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of 99mTc-depreotide in the management of neuroendocrine tumours.
Tahir Shah, Ilona Kulakiene, Ann-Marie Quigley, Victoria S Warbey, Rajaventhan Srirajaskanthan

Nucl Med Commun· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The new EANM paediatric dosage card--does it conform to ALARA for PET/CT?
Victoria S Warbey, Paul J Schleyer, Sally F Barrington, Michael J O'doherty

Eur J Nucl Med Mol Imaging· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis